Filing Flows › Immunome (IMNM) › How it makes money
How Immunome (IMNM) makes money
Immunome (IMNM) made $4.0M of revenue in the second quarter 2025 (Q2 2025), +70% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2025 | % of revenue |
|---|---|---|
| Revenue | $4.0M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2025 | $4.0M | +70% |
| Q1 2025 | $2.9M | +184% |
| Q4 2024 | $2.7M | -28% |
From Immunome's 10-Q filed Aug 6, 2025 (on EDGAR).
Questions
How does Immunome make money?
Immunome (IMNM) made $4.0M of revenue in the second quarter 2025 (Q2 2025), +70% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.